Study marks major milestone for CTH120 as company advances disease‑modifying ambitions More: Connecta launches phase 2a trial of neuroplasticity modulator Source: News
read more
Guidance paves the way for NHS access for eligible adults in England and Wales More: Aquipta recommended by NICE for acute migraine treatment Source: News
read moreThe CEO voiced his concerns about Germany’s new healthcare reform plan in a letter to Chancellor Friedrich Merz, according to reports. More: Pfizer CEO Bourla reconsiders German investments as industry takes aim at healthcare reform plan: Reuters Source: fierce
read moreBay Area biotech SonoThera is bubbling to a clinical boil after raising a $125 million series B with the backing of some of the biggest names in pharma. More: Big Pharma-backed SonoThera sounds off with 5M series B for bubble-based
read moreTeva plans to remove 250 jobs at its CDMO unit over the next two years, Israeli business news outlet Globes reports. More: Teva to lay off 250 at API unit as search for new owner drags on: report Source: fierce
read moreGenentech and Novartis have sponsored a four-part microdrama series about young people with food allergies in New York. More: Genentech and Novartis dish up food allergy microdrama series Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals